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Although it is widely appreciated 
that the use of global translation 
inhibitors, such as cycloheximide, in 
protein degradation assays may result in 
artefacts, these inhibitors continue to be 
employed, owing to the absence of robust 
alternatives. We describe here the 
promoter reference technique (PRT), an 
assay for protein degradation with two 
advantageous features: a reference 
protein and a gene-specific inhibition of 
translation. In PRT assays, one measures, 
during a chase, the ratio of a test protein 
to a long-lived reference protein, a 
dihydrofolate reductase (DHFR). The test 
protein and DHFR are coexpressed, in the 
yeast Saccharomyces cerevisiae, on a low-
copy plasmid from two identical PTDH3 
promoters containing additional, 
previously developed DNA elements. 
Once transcribed, these elements form 5’-
RNA aptamers that bind to the added 
tetracycline, which represses translation 
of aptamers-containing mRNAs. The 
selectivity of repression avoids a global 
inhibition of translation. This selectivity is 
particularly important if a component of 
a relevant proteolytic pathway, e.g., a 
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specific ubiquitin ligase, is itself short-
lived. We applied PRT to the Pro/N-end 
rule pathway, whose substrates include 
the short-lived Mdh2 malate 
dehydrogenase. Mdh2 is targeted for 
degradation by the Gid4 subunit of the 
GID ubiquitin ligase. Gid4 is also a 
metabolically unstable protein. Through 
analyses of short-lived Mdh2 as a target 
of short-lived Gid4, we illustrate the 
advantages of PRT over degradation 
assays that lack a reference and/or 
involve cycloheximide. In sum, PRT 
avoids the use of global translation 
inhibitors during a chase and also 
provides a “built-in” reference protein. 
 
In vivo half-lives of intracellular 
proteins range from less than a minute to 
many days (1-6). The term “half-life” is, at 
best, an approximate descriptor of a 
protein’s degradation curve. The reasons for 
this include: (i) A significant (and varying) 
probability of cotranslational degradation of 
a nascent (still being made) polypeptide 
chain (7-12). (ii) The process of 
conformational maturation, i.e., transitions 
from a newly formed, still partially unfolded 
(and often more vulnerable to proteolysis) 
monomer of a protein to its final state, either 
as a folded monomer or an oligomer of the 
homo or hetero kind. Mature proteins are 
usually more resistant to proteolysis, in part 
through steric shielding of their degradation 
signals (degrons) (4,5,13-19). (iii) A variety 
of chemical (usually enzymatic) 
modifications of a protein that can change 
its metabolic stability either 
cotranslationally or posttranslationally. For 
example, phosphorylation of a protein may 
either activate or inhibit its degron (20-27). 
(iv) Posttranslational in vivo cleavage(s) of a 
protein by a nonprocessive protease such as, 
for instance, a calpain or a caspase (28-30). 
The rates of subsequent degradation of the 
resulting protein fragments can be quite 
dissimilar. The in vivo destruction of a 
protein usually involves either its 
polyubiquitylation, followed by the 
proteasome-mediated degradation, or the 
entrapment of a protein in an 
autophagosome, followed by the lysosome-
mediated proteolysis. Some proteins can be 
targeted through both of these routes 
concurrently, depending on the nature of a 
protein, its degron(s), and physiological 
state of a cell (31). 
These and other complexities of 
intracellular protein degradation make it 
particularly important to have the means for 
determining the in vivo decay curves of 
specific proteins with high accuracy and 
through methods that do not perturb the 
rates of proteolysis that these methods are 
designed to measure. A variety of protein 
degradation assays are currently in use, 
including pulse-chases as well as proteome-
scale techniques based on mass 
spectrometry (19,32-48). 
One class of widely employed 
approaches, historically among the first to 
be introduced, are assays for in vivo protein 
degradation that involve the use of a global 
translation inhibitor to halt protein synthesis, 
followed by measurements of decreasing 
levels of a protein of interest (a “chase”) by 
SDS-PAGE and immunoblotting, or by 
other means. The resulting decay curves are 
usually calibrated by measuring, in parallel, 
the levels of an abundant endogenous 
protein (e.g., tubulin or actin) that is 
presumed to be both long-lived and 
expressed at approximately equal levels 
under different physiological conditions and 
in varying genetic backgrounds. 
A shortcoming, in the context of 
these assays, of a global translation inhibitor 
such as, for example, cycloheximide (CHX), 
is not only the inhibitor’s cytotoxicity but 
also the fact that a proteolytic pathway 
under study may itself involve a short-lived 
protein(s). Naturally unstable components of 
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specific proteolytic systems continue to be 
identified (49-53). In all such cases, a global 
halt to the synthesis of cellular proteins 
would perturb the very process that a 
degradation assay is meant to measure, since 
the activity of a relevant proteolytic pathway 
would start to decrease as soon as its short-
lived component is no longer produced. In 
addition and independently, it can be 
problematic to calibrate chase-based 
degradation assays by measuring the relative 
amounts of endogenous “marker” proteins, 
inasmuch as their levels often change in 
response to altered physiological conditions 
or genetic backgrounds. 
Two of our 2017 studies described 
and employed a degradation assay termed 
the promoter reference technique (PRT) 
(54,55). Key features of PRT are (i) a 
coexpression, from identical transcriptional 
promoters, of a test protein and a long-lived 
reference protein; and (ii) a gene-specific 
(i.e., not global) inhibition of translation 
during a chase (Fig. 1). In the present work, 
this technique is described in detail (Figs. 1-
4), was further optimized, and was also 
used, in specific PRT-based degradation 
assays, to demonstrate a significant 
downside of using a global translation 
inhibitor, in comparison to a gene-specific 
inhibition of translation (Fig. 4). 
 
Results and Discussion 
 
PRT vis-à-vis the Pro/N-end rule 
pathway 
The promoter reference technique 
(PRT) is described below through its 
applications to one of N-end rule pathways 
(Fig. 1 and Fig. S1). These pathways are a 
set of proteolytic systems whose unifying 
feature is their ability to recognize proteins 
containing N-terminal degradation signals 
called N-degrons, thereby causing the 
degradation of these proteins, largely by the 
proteasome (and also by autophagy) in 
eukaryotes and by the proteasome-like 
ClpAP protease in bacteria (4,54-64).  
The main determinant of an N-
degron is a destabilizing N-terminal residue 
of a protein. Initially, most N-degrons are 
pro-N-degrons. They are converted to active 
N-degrons either constitutively (e.g., during 
the emergence of a nascent protein from a 
ribosome) or conditionally, via regulated 
steps. A pro-N-degron can become an N-
degron through a site-specific cleavage of a 
protein by a protease and/or through 
enzymatic acetylation, formylation, 
arginylation, or leucylation of specific 
proteins at the α-amino group of their 
N-terminal residues. Studies over the last 
three decades have shown that all 20 amino 
acids of the genetic code can act, in cognate 
sequence contexts, as destabilizing 
N-terminal residues (Fig. S1). Consequently, 
many, possibly most, proteins in a cell are 
conditionally short-lived N-end rule 
substrates, either as full-length proteins or as 
protease-generated natural protein fragments 
(54,55,65). Recognition components of N-
end rule pathways are called N-recognins. 
Regulated degradation of proteins and their 
fragments by the N-end rule pathways has 
been shown to mediate a remarkably wide 
range of biological processes (Fig. S1) 
(4,54-77).  
Eukaryotes contain three N-end rule 
pathways (Fig. S1 and its legend). One of 
these proteolytic systems, termed the Pro/N-
end rule pathway, is mediated, in S. 
cerevisiae, by the multisubunit GID Ub 
ligase. Gid4, a subunit of GID that functions 
as the Pro/N-recognin, targets proteins that 
bear the N-terminal Pro residue or a Pro at 
position 2, in addition to adjoining and also 
required sequence motifs (54) (Fig. S1C). 
Physiological substrates of the S. cerevisiae 
Pro/N-end rule pathway include the 
gluconeogenic enzymes Fbp1, Mdh2, Icl1, 
and Pck1, which are long-lived in cells 
deprived of glucose but are selectively 
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destroyed upon return to glucose-replete 
conditions (Fig. S1C) (54,78,79). 
Degradation assays of the present study 
focus on Mdh2, a physiological substrate of 
the Pro/N-end rule pathway (Fig. S1C). 
 
The promoter reference technique 
(PRT) 
Fig. 1 illustrates PRT. A plasmid, 
based on the low copy S. cerevisiae-E. coli 
pJO629 vector (see Experimental 
Procedures), contains the required PRT 
elements, including an ORF encoding an 
epitope-tagged protein of interest (“test 
protein-flag3”) (Fig. 1C). The test protein 
and a long-lived reference protein (an 
epitope-tagged mouse DHFR) are 
coexpressed, in S. cerevisiae, from a 
pJO629-based plasmid and its two identical 
PTDH3 promoters containing additional DNA 
elements, developed by Kötter et al. (80). 
Once transcribed into an mRNA, these 
elements form 5’-RNA aptamers that can 
bind to tetracycline (Tc), thereby repressing 
translation of that mRNA in cis (Fig. 1B, C). 
As a protein degradation assay, PRT 
has two advantageous features: a “built-in” 
reference protein and the possibility of using 
a Tc-mediated, gene-specific (i.e., non-
global and therefore largely nontoxic) 
repression of translation (Fig. 1B, C). The 
logic of PRT (Fig. 1A) is not confined to Tc 
as a gene-specific translation inhibitor. It 
should also be possible to develop PRT 
assays that employ, for example, other 
transcriptional promoters and/or 
aptamer-mediated regulatory elements 
specific for small compounds other than Tc. 
Fig. 2 illustrates the use of Tc-based 
PRT to characterize the degradation of 
Mdh2, a gluconeogenic enzyme. When 
glucose is low or absent, cells synthesize it 
through gluconeogenesis, an ATP-
consuming process (81). When S. cerevisiae 
grow on ethanol as a carbon source, 
gluconeogenic enzymes such as Mdh2 are 
expressed and long-lived. Transition to a 
medium containing glucose inhibits the 
synthesis of gluconeogenic enzymes and 
induces their degradation, which is mediated 
by the multisubunit GID Ub ligase 
(54,78,79). Gid4, a subunit of GID, was 
recently identified as the N-recognin of a 
distinct N-end rule pathway, termed the 
Pro/N-end rule pathway (Fig. S1C) (54). 
Gid4 recognizes the N-terminal Pro residue 
of Mdh2 in the context of an also required 
adjoining sequence motif (54). Previous 
work showed that Gid4, which is absent in 
yeast growing on ethanol, is an expressed 
but short-lived protein in cells that grow in a 
glucose-containing medium (82). 
Our 2017 study of the Pro/N-end rule 
pathway involved Tc-chases with the 
gluconeogenic enzymes Mdh2, Fbp1, and 
Pck1 (54). To avoid repetition, Fig. 2 shows 
a previously unpublished set of PRT-based 
Mdh2 results. These assays involved wild-
type and gid2Δ S. cerevisiae carrying PRT-
based plasmids (Fig. 1C) that expressed 
either the 377-residue, C-terminally 
flag-tagged P-Mdh23f (bearing N-terminal 
Pro) or its otherwise identical mutant 
S-Mdh23f, bearing N-terminal Ser. gid2Δ 
cells lack an essential subunit of the GID Ub 
ligase and therefore lack the Pro/N-end rule 
pathway (Fig. S1C). After 18 hours in 
ethanol medium at 30°C, cells were shifted 
to a glucose medium while the synthesis of 
both the fDHFRha reference protein and 
X-Mdh23f proteins was repressed by Tc, 
initiating a chase (Fig. 2). Under these 
conditions, P-Mdh23f (its initially present N-
terminal Met is cotranslationally removed 
by Met-aminopeptidases (4)) was short-lived 
in wild-type cells (t1/2 of ~30 min) but was 
much more stable in gid2Δ cells, which 
lacked the activity of GID (Fig. 2A, lanes 2-
5; compare to lanes 6-9; and Fig. 2B). In 
contrast, the S-Mdh23f  mutant, bearing 
N-terminal Ser instead of Pro, was 
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long-lived even in wild-type cells (Fig. 2A, 
lanes 10-17; and Fig. 2B).  
 
Optimizing the level of tetracycline 
during a chase 
The concentration of Tc used for 
gene-specific inhibition of translation in 
PRT-based chases of Fig. 2 was 0.2 mM. 
The same level of Tc was used in our 2017 
studies that introduced and briefly described 
PRT (54,55). In the present work, we wished 
to determine whether 0.2 mM Tc was an 
optimal concentration, i.e., whether it was 
low enough to cause no detectable 
cytotoxicity and high enough to result in a 
non-leaky gene-specific repression of 
translation. We found that 0.5 mM Tc was 
preferable to the also acceptable but slightly 
“leaky” 0.2 mM Tc (Fig. 3).  
In contrast to assays in Figs. 2 and 4, 
which involved Mdh2, the Tc-optimization 
experiments described in Fig. 3 involved S. 
cerevisiae Chk1, a mitotic checkpoint 
kinase. Chk1 and several other yeast 
proteins were recently identified as 
conditionally short-lived physiological 
substrates of the Ubr1-mediated Arg/N-end 
rule pathway (55). The Ubr1-containing 
targeting complex of this pathway (Fig. 
S1A) was shown to recognize a C-terminus-
proximal degron of the Chk1 protein (55). 
Our sole aim, in the experiments of Fig. 3, 
was to determine a level of Tc that would be 
optimal for PRT assays. Therefore we used 
the ubr1Δ JOY379 S. cerevisiae strain 
(lacking the Arg/N-end rule pathway), in 
which Chk1 was long-lived. JOY379 cells 
carried a PRT-based plasmid (Fig. 1C) 
expressing the epitope-tagged Chk13f protein 
and the fDHFRha reference protein (55). 
Tc was added, to different final 
levels (varying from 0.1 to 0.5 mM, as 
indicated in Fig. 3), to identical samples of 
JOY379 S. cerevisiae. After a time interval 
in the presence of Tc that varied from zero 
to 20 min, cell suspensions were pulse-
labeled for 3 min with 35S-Met/Cys (see 
Experimental Procedures), followed by 
extraction of proteins, immunoprecipitation 
of Chk13f and fDHFRha with anti-flag 
antibody, SDS-PAGE and autoradiography. 
Fig. 3, lanes 1-9 show the SDS-PAGE 
results with total 35S-pulse-labeled proteins, 
before anti-flag immunoprecipitation. Fig. 3, 
lanes 10-18 show the same samples from 
35S-pulse-labeled cells but after anti-flag 
immunoprecipitation. 
None of examined concentrations of 
Tc, including 0.5 mM, caused significant 
changes in the levels (or patterns) of total 
35S-pulse-labeled proteins, indicating that Tc 
did not significantly influence global 
cytosolic translation (Fig. 3, lanes 1-9). Fig. 
3, lanes 10-18 shows the bands of 35S-
labeled (immunoprecipitated) Chk13f and 
fDHFRha, the two proteins expressed from 
mRNAs whose translation was repressed by 
Tc. In particular, lanes 10-15 show 35S-
labeled Chk13f and fDHFRha in cells that 
were incubated with 0.1 mM Tc for either 
zero, 2, 4, 8, 15, or 20 min before the 
beginning of a 3-min 35S-Met/Cys pulse. 
The 35S-labeling of Chk13f and fDHFRha 
“flattened out” by 15 min after the addition 
of Tc (to the final concentration of 0.1 mM), 
and was much lower than the 35S-labeling 
immediately after the addition of Tc (Fig. 3, 
lane 10; compare with lane 15), indicating a 
gene-specific inhibition of translation by Tc.  
The levels of 3-min 35S-labeling of 
Chk13f and fDHFRha 20 min after the 
addition of Tc decreased to essentially 
undetectable (at this and significantly longer 
autoradiographic exposures) at the Tc 
concentration of 0.5 mM (Fig. 3, lane 18), 
and to low but still detectable levels at the 
Tc concentration of 0.2 mM (Fig. 3, lane 16; 
compare with lane 18). We concluded that 
0.5 mM Tc yielded an approximately 
optimal level of gene-specific inhibition of 
translation in PRT assays, as this 
concentration of Tc was sufficiently “non-
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leaky” while still without effects on either 
the level or pattern of total protein synthesis 
(Fig. 3, lane 9). 
 
Comparing a PRT-based 
cycloheximide-chase to a PRT-based 
tetracycline-chase 
Global translation inhibitors such as 
cycloheximide (CHX) continue to be widely 
used in studies that involve chase-based 
degradation assays. As mentioned in the 
Introduction, a major shortcoming of global 
translation inhibitors, in the context of 
chases, stems from the fact that a proteolytic 
pathway under study may itself involve a 
short-lived protein(s) (49-53). In such cases, 
a halt to the synthesis of cellular proteins 
would perturb the very process that a 
degradation assay is meant to measure, since 
the activity of a relevant proteolytic pathway 
would start to decrease as soon as its 
unstable component is no longer produced. 
Inasmuch as the Gid4 Pro/N-recognin of the 
Pro/N-end rule pathway that targets P-
Mdh23f for degradation (Fig. 2 and Fig. 
S1C) is known to be a short-lived protein 
(82), we asked whether results of a PRT-
based Tc-chase with P-Mdh23f would 
significantly differ from an otherwise 
identical PRT-based CHX-chase. 
These assays were carried out 
identically to the ones described in Fig. 2, 
except that the concentration of Tc during 
chase was 0.5 mM (instead of 0.2 mM Tc in 
the assays of Fig. 2), and cells were grown 
in a glucose-containing medium before and 
during chases. Both PRT-based Tc-chase 
and PRT-based CHX-chase assays with P-
Mdh23f detected the in vivo degradation of 
P-Mdh23f, in contrast to the metabolic 
stability and much higher time-zero (before-
chase) levels of S-Mdh23f (Fig. 4). 
Remarkably, however, the actual decay 
curves of P-Mdh23f were quite different 
when determined using Tc-chase, in 
comparison to CHX-chase.  
Specifically, the time-zero levels of 
P-Mdh23f, at the beginning of both chases, 
were nearly identical to each other (Fig. 4A, 
lanes 2 vs. lane 10; and Fig. 4B). However, 
while the rapid degradation of P-Mdh23f 
continued throughout 2 hours of Tc-chase, 
the degradation of P-Mdh23f during an 
otherwise identical CHX-chase was not as 
fast. Moreover, the degradation curve of 
CHX-chase “flattened out” after 30 min, in 
contrast to the results with Tc-chase (Fig. 4, 
lanes 2-5 vs. lanes10-13; and Fig. 4B). 
To the best of our knowledge, these 
results are the first direct and rigorously 
controlled evidence for a significant 
distortion of an in vivo decay curve of a 
protein in a PRT-based chase that involves a 
global translation inhibitor, in comparison to 
the otherwise identical PRT-based chase that 
utilizes Tc (Fig. 4). Since Gid4, the N-
recognin of the Pro/N-end rule pathway 
(Fig. S1C), is a short-lived protein (82), the 
above results were in agreement with the a 
priori expectation of a difference between 
these PRT-based chase patterns (Fig. 4). 
Thus, at least in the setting of the Pro/N-end 
rule pathway, a chase that employs a global 
translation inhibitor such as CHX would 
underestimate the actual rate of degradation 
of a protein of interest, owing to the 
pathway-inhibition effect detected and 
described above (Fig. 4). 
 
Concluding remarks 
The tetracycline (Tc)-based promoter 
reference technique (PRT) (Figs. 1-4) has 
two independently advantageous features: a 
“built-in” reference protein and a gene-
specific inhibition of translation during a 
chase. A long-lived reference protein, the 
epitope-tagged DHFR in the present version 
of PRT (Figs. 1C and 4A), addresses the 
problem of data scatter in reference-lacking 
pulse-chase assays and immunoblotting-
based chase assays. The presence of a 
reference protein makes it possible to 
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measure the level of a test protein during a 
chase as the ratio of its level to that of the 
reference at a given chase time. 
Consequently, in both immunoblotting-
mediated chases and radioactive 
labeling-mediated pulse-chases, a reference-
based and ratio-based measurement can 
compensate for the scatter of labeling 
efficiencies, scatter of immunoprecipitation 
(and/or immunoblotting) yields, 
imprecisions in sample volumes, and other 
sources of sample-to-sample variation. The 
resulting robustness and higher accuracy of 
reference-based degradation assays also 
makes it easier to detect and measure, at the 
start of a chase, the “early”, before-chase 
degradation of a test protein (Figs. 2 and 4). 
In addition to optimizing Tc 
concentration in PRT (Fig. 3), we also 
demonstrated, through specific PRT-based 
degradation assays, the significant downside 
of using a global translation inhibitor, in 
comparison to a gene-specific inhibition of 
translation (Fig. 4). An extension of 
Tc-based PRT from its described use in S. 
cerevisiae (Figs. 1-4) to multicellular 
eukaryotes, including mammalian cells, is 
highly desirable and should be feasible, but 
is not technically straightforward, since the 
set of RNA aptamers that works in yeast 
(Figs. 1B, 2 and 4) did not suffice, so far, 
with mammalian cells (80). 
 
Experimental procedures 
 
Antibodies and other reagents 
The antibodies used were anti-flag 
mouse M2 monoclonal antibody (Sigma, 
F1804) and anti-ha rabbit monoclonal 
antibody (Sigma, H6908). Fluorescence of 
immunoblots were quantified using 
Odyssey-9120 (Li-Cor, Lincoln, NE). 
Secondary antibodies for immunoblotting 
were Li-Cor IRDye-conjugated goat anti-
mouse 800CW (Li-Cor, C60405-05) or anti-
rabbit 680RD (Li-Cor, C51104-08). Other 
reagents included “complete protease 
inhibitor cocktail” tablets (Roche, 
11697498001); protease inhibitor cocktail 
“for use with fungal and yeast extracts” 
(Sigma, P8215); phenylmethylsulfonyl 
fluoride (Sigma, P7626); cycloheximide 
(CHX) (Sigma, C7698); and tetracycline 
(Tc) (Sigma, T3383). 
 
Genetic techniques, media, yeast 
strains, and plasmids 
Standard techniques were used for 
strain construction and transformation 
(54,55,83,84). S. cerevisiae media included 
YPD (1% yeast extract, 2% peptone, 2% 
glucose; only most relevant components are 
cited); SD medium (0.17% yeast nitrogen 
base, 0.5% ammonium sulfate, 2% glucose); 
and synthetic complete (SC) medium 
(0.17% yeast nitrogen base, 0.5% 
ammonium sulfate, 2% glucose), plus a 
drop-out mixture of compounds required by 
specific auxotrophic strains. The S. 
cerevisiae strains used in this work were 
BY4741 (MATa his3-1 leu2-0 Met15-0 
ura3-0), BY4742 (MATα his3-1 leu2-0 lys2-
0 ura3-0 can1-100), and JOY379 (a 
ubr1∆::HphNT1 derivative of the BY4742 
strain) (54,55). The plasmids pJO629 (a 
parent of the “generic” PRT plasmid 
encoding a C-terminally epitope-tagged test 
protein and the fDHFRha reference (Fig. 
1C)), pCSJ125 (a PRT-based plasmid 
encoding P-Mdh23f and the fDHFRha 
reference), pCSJ126 (an otherwise identical 
plasmid encoding S-Mdh23f and the 
fDHFRha reference), and pJO630 (a PRT-
based plasmid encoding Chk13f and the 
fDHFRha reference) were constructed and 
described previously (54,55). pJO629 and 
plasmids derived from it contained two 
direct repeats of a relatively long nucleotide 
sequence (PTDH3 promoter and the adjoining 
aptamers-forming DNA segment) (Fig. 1), a 
recombinogenic configuration. Therefore a 
small fraction of S. cerevisiae that received a 
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pJO629-derived plasmid (about 5% of 
transformants, in our experience) contained 
recombination-produced derivatives of that 
plasmid. This minor complication could be 
dealt with by discarding transformants that 
failed to produce the correctly sized 
fDHFRha reference and/or a test protein. 
 
PRT-based degradation assays 
These assays used low copy pJO629-
based plasmids that expressed a C-
terminally triple-flag-tagged test protein and 
the long-lived, also tagged fDHFRha 
reference protein from a pair of identical 
PTDH3-based promoters. In this setting, the 
synthesis of both proteins could be 
selectively extinguished by the addition of 
tetracycline (Tc) (Fig. 1). Initially, the final 
concentration of Tc was 0.2 mM (Fig. 2). It 
became 0.5 mM in later PRT assays (Figs. 3 
and 4). When cycloheximide (CHX), a 
global translation inhibitor, was used instead 
of Tc, it was at 0.36 mM (0.1 mg/ml). As 
described in Results (Fig. 3), 0.5 mM Tc 
was found to be preferable to the also 
acceptable but slightly “leaky” 0.2 mM Tc, 
the level used for Tc-chases in our earlier 
work (54,55) and also, initially, during the 
present study. Neither 0.2 mM nor 0.5 mM 
Tc detectably altered the growth rate of S. 
cerevisiae. 
S. cerevisiae were grown to A600 of ~ 
1.0 in selective liquid media at 30°C, 
followed by treatment with 0.2 mM Tc (and 
in later assays, with the actually 
recommended Tc concentration of 0.5 mM; 
see Results and Discussion). When CHX 
was used instead of Tc, it was at the CHX 
concentration of 0.36 mM (0.1 mg/ml). At 
indicated times, cell samples (corresponding 
to 1 ml of cell suspension at A600 of ~1.0) 
were harvested by centrifugation for 1 min 
at 3,000 rpm in a low-speed centrifuge. The 
pellet was resuspended in 0.8 ml of ice-cold 
water for 5 min, followed by centrifugation 
for 1 min at 3,000 rpm as above, and 
resuspension in 0.8 ml of 0.2 M NaOH for 5 
min on ice. The resulting suspension was 
centrifuged for 5 min at 21,130g. The pellet 
was resuspended in 50 μl of HU buffer (8 M 
urea, 5% SDS, 1 mM EDTA, 0.1 M 
dithiothreitol (DTT), 0.005% bromophenol 
blue, 0.2 M Tris-HCl, pH 6.8) containing 
1×protease inhibitor cocktail (Roche) and 
1×protease inhibitor cocktail “for use with 
fungal and yeast extracts” (Sigma), and 
heated for 10 min at 70C. After 
centrifugation for 3 min at 21,130g, 15 l of 
each supernatant was used to carry out SDS-
4-12% NuPAGE (Invitrogen), followed by 
immunoblotting, performed as described 
previously (14,54,55,75), using a mixture of 
anti-ha (1:2,000) and anti-flag (1:2,000) 
antibodies. Immunoblots were processed 
using secondary antibodies labeled with 
different fluorophores. Visualized protein 
bands were quantified using the Odyssey-
9120 Imaging System (Li-Cor).The 
near-infrared fluorescence range and other 
features of the Odyssey scanner facilitate 
quantification of immunoblots. 
 
Optimizing the level of tetracycline 
during chase 
pJO630, a PRT-based plasmid (Fig. 
1C) that expressed the flag epitope-tagged 
Chk13f protein and the fDHFRha reference 
protein, was described previously (55). See 
the main text for a brief introduction of 
Chk1, a kinase and a physiological substrate 
of the Arg/N-end rule pathway (55) (Fig. 
S1A). S. cerevisiae JOY379 cells 
(ubr1∆::HphNT1 in the BY4742 strain 
background) that lacked the Arg/N-end rule 
pathway and carried pJO630 were grown at 
30°C to A600 of ~1 in 50 ml of SC medium 
without histidine (SC-His). Nine 15-ml 
tubes were filled, each, with 5 ml of cell 
suspension, followed by pelleting of cells by 
a low-speed centrifugation, and washing the 
pellets in 0.8 ml of SD medium (see above) 
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supplemented with Lys, Trp, Leu, and Ura 
(83).  
Cells were pelleted again and 
resuspended in 0.4 ml of fresh SD medium, 
followed by incubation at 30°C for 20 min. 
Tc was added to cell suspensions, to the 
varying final concentrations of 0.1 mM, 0.2 
mM, 0.3 mM, or 0.5 mM, either at the start 
of 20-min incubation, or during it, or 
immediately after it (see the legend to Fig. 3 
for details). Thereafter (at the end of 20-min 
incubation) cell suspensions were labeled 
for 3 min at 30°C with 0.16 mCi of 
35S-EXPRESS Met/Cys (Perkin-Elmer), 
followed by centrifugation to pellet the cells, 
their resuspension in 0.1 ml of amino acids-
supplemented SD medium, and their 
freezing, immediately afterward, in liquid 
nitrogen. To process the samples further, 0.8 
ml of lysis buffer (10% glycerol, 0.5% 
NP40, 0.2 M KCl, 1 mM PMSF, 5 mM β-
mercaptoethanol, 50 mM HEPES, pH 7.5) 
was added to each frozen sample, and 
extracts was prepared using Mini-
Beadbeater-16 (BioSpec) (4 times for 20 sec 
each at maximum speed, with 5-min 
intervals on ice). The extracts were 
centrifuged at 21,000g for 15 min at 4°C, 
and the supernatants were centrifuged 
(identically) again. 15 μl of each sample was 
taken and later analyzed as input samples. 
The rest of supernatants were processed for 
immunoprecipitation, using 8 μl of a 
suspension of anti-flag antibody 
immobilized on magnetic beads (Sigma). 
Immunoprecipitates were analyzed by 
SDS-4-12% NuPAGE (Invitrogen) and 
autoradiography. 
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FIGURE LEGENDS 
 
Figure 1. The promoter reference technique (PRT).  
A, PRT design: two identical transcriptional promoters expressing, respectively, a test 
protein and a reference protein. B, Identical sets of DNA elements, developed by Kötter et al. 
(80), that are present at the two identical, tandem PTDH3 promoters in the current version of PRT. 
C, A “generic” PRT plasmid, derived from the previously described pJO629 plasmid (54,55). It 
contains DNA elements that enable propagation of this plasmid in E. coli (including the 
ampicillin-encoding amp gene and the origin of DNA replication from the E. coli plasmid 
pBR322) and in S. cerevisiae (as a low copy plasmid), including the HIS3 marker gene, the 
replication/segregation CEN-ARS DNA segment, and the CYC1-derived transcription-
terminating DNA segment. This plasmid also encodes the flag/ha-tagged fDHFRha reference 
protein and a C-terminally triple-flag tagged test protein. In the present study, the test proteins 
were X-Mdh23f bearing either N-terminal Pro or N-terminal Ser, as described in the main text 
(Figs. 3 and 5). The test protein and the reference protein are expressed from two identical PTDH3 
promoters containing additional DNA elements (80). Once transcribed into an mRNA, these 
elements form 5’-RNA aptamers that can bind to tetracycline (Tc), thereby repressing translation 
of that mRNA in cis. 
 
Figure 2. PRT-based chase assays with Mdh2. 
A, S. cerevisiae Mdh2 is the cytosolic malate dehydrogenase and a substrate of the 
GID-mediated Pro/N-end rule pathway (54). Lane 1, kDa markers. Tetracycline (Tc)-based 
chases were performed at 30°C during transition from ethanol to glucose media (see 
Experimental Procedures) with wild-type (lanes 2-5 and 10-13) or gid2∆ S. cerevisiae (lanes 6-9 
and 14-17) expressing the fDHFRha reference and either wild-type P-Mdh23f (bearing N-terminal 
Pro; lanes 2-9) or S-Mdh23f (bearing N-terminal Ser; lanes 10-17). At the indicated times of a 
chase, proteins in cell extracts were fractionated by SDS-PAGE followed by immunoblotting 
with anti-flag antibody. The bands of X-Mdh23f test proteins and the fDHFRha protein are 
indicated on the right. B, Quantification of the data in A. The time-zero (before-chase) level of S-
Mdh23f in gid2∆ cells was taken as 100%. Note the much lower time-zero level (40%) of the 
short-lived, wild-type P-Mdh23f in wild-type cells. Its half-life (the time it took for the level of P-
Mdh23f to decrease from the initial 40% to 20%) was approximately 20 min. All chases in this 
study were performed at least twice and yielded results that differed by less than 10%.  
 
Figure 3. Optimizing the level of tetracycline during a chase. 
ubr1∆ S. cerevisiae carried the previously described (55), PRT-based plasmid pJO630 
that expressed the Chk13f protein and the fDHFRha reference protein (see Experimental 
Procedures and the main text for a brief introduction of the mitotic checkpoint kinase Chk1, a 
physiological substrate of the Arg/N-end rule pathway). Cells were labeled for 3 min at 30°C 
with 35S-EXPRESS Met/Cys at specified times after the addition of tetracycline (Tc) to varying 
indicated final concentrations. Lanes 1-9, total 35S-labelling patterns, before 
immunoprecipitation. Lanes 10-18, same as lanes 1-9 but after immunoprecipitation of labeled 
cell extracts with anti-flag antibody. Lane 1, no addition of Tc before 3-min pulse with 
35S-EXPRESS Met/Cys. Lanes 2-6 and 10-15, Tc was added to cells to the final concentration of 
0.1 mM, followed by incubation for 2, 4. 8, 15 and 20 min respectively, before 3-min pulse with 
35S-EXPRESS Met/Cys. Lanes 7-9 and 16-18, Tc was added to cells to the final concentrations 
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of 0.2 mM, 0.3 mM and 0.5 mM, respectively, followed by incubation for 20 min and 3-min 
pulse with 35S-EXPRESS Met/Cys. See the main text for additional details. 
 
Figure 4. Comparing a PRT-based tetracycline-chase to a cycloheximide-chase. 
PRT-based Tc-chases and CHX-chases were carried out with wild-type S. cerevisiae 
growing in SC medium and expressing either P-Mdh23f (bearing N-terminal Pro) or S-Mdh23f 
(bearing N-terminal Ser). A, Lane 1, kDa markers. Lanes 2-5, CHX-chase, for 0, 0.5, 1 and 2 
hours, with P-Mdh23f. Lanes 6-9, same as lanes 2-5 but with S-Mdh23f. Lanes 10-13, same as 
lanes 2-5 but a Tc-chase. Lanes 14-17, same as lanes 6-9, but a Tc-chase. The bands of 
X-Mdh23f test proteins and the fDHFRha protein are indicated on the right. B, Quantification of 
the data in A. The time-zero (before-chase) level of S-Mdh23f in the Tc-chase was taken as 
100%. Note the time-zero, before-chase degradation of ~85% of P-Mdh23f, relative to S-Mdh23f, 
and the similar time-zero levels (in contrast to subsequent levels) of P-Mdh23f in the Tc-chase vs. 
the CHX-chase. Note, also, the lower rate of P-Mdh23f decrease (and the subsequent flattening of 
decay curve) in the CHX-chase, in comparison to the Tc-chase. All chases in this study were 
performed at least twice and yielded results that differed by less than 10%. See also the main 
text. 
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Fig. 1, Oh et al.
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Fig. 2, Oh et al.
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Fig. 3, Oh et al.
1 2 3 4 5 7 8 96 10 11 12 13 14 15 16 17 18
S-proteins, total35
Tc (mM):
S-proteins, IP-ed with anti-flag Ab35
Chk13f
DHFRf ha
0 0.1 0.1 0.1 0.1 0.2 0.3 0.50.1 0 0.1 0.1 0.1 0.1 0.2 0.3 0.50.1
35Time (min) between the addition of Tc and a 3-min    S-Met pulse 
0 2 4 8 15 20 20 2020 0 2 4 8 15 20 20 2020
Optimization of Tc concentration for a Tc-chase
 at CA
LIFO
RN
IA
 IN
STITU
TE O
F TECH
N
O
LO
G
Y
 on N
ovem
ber 13, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Fig. 4, Oh et al.
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